10.23
+0.09(+0.89%)
Currency In USD
| Previous Close | 10.14 |
| Open | 10.17 |
| Day High | 10.25 |
| Day Low | 9.99 |
| 52-Week High | 19.09 |
| 52-Week Low | 9.41 |
| Volume | 278,436 |
| Average Volume | 1.19M |
| Market Cap | 985.78M |
| PE | -13.64 |
| EPS | -0.75 |
| Moving Average 50 Days | 12.17 |
| Moving Average 200 Days | 14.78 |
| Change | 0.09 |
If you invested $1000 in Avadel Pharmaceuticals plc (AVDL) 10 years ago, it would be worth $597.9 as of December 26, 2024 at a share price of $10.23. Whereas If you bought $1000 worth of Avadel Pharmaceuticals plc (AVDL) shares 5 years ago, it would be worth $1,411.03 as of December 26, 2024 at a share price of $10.23.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy
GlobeNewswire Inc.
Dec 11, 2024 1:00 PM GMT
– Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose among the key challenges – DUBLIN, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutica
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
GlobeNewswire Inc.
Nov 13, 2024 1:00 PM GMT
DUBLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12
GlobeNewswire Inc.
Nov 04, 2024 1:00 PM GMT
DUBLIN, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m.